Here are some of the studies we mentioned in Episode 13!
Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study by Josephine Marschall et al 2022
Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study by Fedrico Cavanna et al 2022
Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non‐microdosers by Joseph M. Rootman et al 2021
Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing by L. S. Kaertner et al 2021
Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls by Joseph M. Rootman et al 2022
Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers by Nadia R. P. W. Hutten et al 2019
Self-blinding citizen science to explore psychedelic microdosing by Balázs Szigeti et al 2021
Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants by Frederick Holze et al 2021
Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting by Luisa Prochazkova et al 2018
Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration by James Fadiman and Sophia Korb 2019
Psychedelic Microdosing, Mindfulness, and Anxiety: A Cross-Sectional Mediation Study by Vincent Hartong and Arnold van Emmerik 2022
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research by Kim PC Kuypers 2019
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732823/
Asking questions of psychedelic microdosing by Lindsay P. Cameron 2021
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924944/